Tuesday, 22 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14467
Articles
Company
Drug
Boehringer Ingelheim Wins Patent Infringement Ruling Against HEC Over Trajenta
February 17, 2025
Company
Drug
Zelgen’s Jacktinib Hits Phase IIb Endpoint in Myelofibrosis Study
February 17, 2025
Company
Medical Device
Wision A.I.’s Polyp Detection Software Secures NMPA Approval for Colonoscopy Use
February 17, 2025
Company
Medical Device
Ethicon’s Hemostatic Granules Win NMPA Approval for Endoscopic Surgery Use
February 17, 2025
Company
Deals
Bloomage Biotech Terminates Medytox Pact Over Botox Supply Issues
February 17, 2025
Company
Deals
WuXi Biologics Partners with AstraZeneca for Local Production of Evusheld
February 17, 2025
Company
Deals
Structure Therapeutics Oversubscribes USD33m on Top of USD100m Series B Round
February 17, 2025
Company
Drug
Ascletis Pharma’s ASC10 Receives IND Approval for COVID-19 Treatment in US and China
February 17, 2025
Company
Drug
ProfoundBio Receives FDA Approval for PRO1184, Appoints New CMO
February 17, 2025
Company
AstraZeneca’s H1 2022 Revenues Surge 48%, Led by Oncology and Vaccines
February 17, 2025
Company
Drug
Lee’s Pharma Completes Enrollment for NVK-002 Myopia Trials in China
February 17, 2025
Company
Drug
Lynk Pharma Gets NMPA Green Light for LNK01004 Atopic Dermatitis Study
February 17, 2025
1
2
…
1,164
1,165
1,166
1,167
1,168
…
1,205
1,206
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?